Assessment of Lactobacillus casei rhamnosus (LGG) therapy in children with biliary atresia - Randomized placebo controlled trial.
- 2021-11
- RCT · n = 16
- Clinics and research in hepatology and gastroenterology 45(6)
- Ewa Orłowska
- Piotr Czubkowski
- Katarzyna Wołochowska
- Dorota Jarzębicka
- Ilona Motyl
- Piotr Socha
- PubMed: 34311135
- DOI: 10.1016/j.clinre.2021.101753
- High evidence
- Clinical
The level of total bilirubin decreased below 2 mg/dl after 6 months of the study in 6 (42.8%) patients in the LGG group and in 8 (50%) patients in the placebo group (p = 0.73).
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- Not stated in abstract